RAPID MICRO BIOSYSTEMS INC
For the period ended Dec 31, 2024. Filed Feb 28, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 28, 2025
RPID$0.75+3.2%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets as of December 31, 202 and
(In thousands, except share and per share amounts)
| December 31, | ||
|---|---|---|
| 2024 | 2023 | |
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $16,911 | $24,285 |
| Short-term investments | 33,821 | 67,768 |
| Accounts receivable | 7,519 | 5,532 |
| Inventory | 20,200 | 19,961 |
| Prepaid expenses and other current assets | 2,466 | 2,869 |
| Total current assets | 80,917 | 120,415 |
| Property and equipment, net | 11,193 | 12,832 |
| Right-of-use assets | 5,163 | 6,240 |
| Long-term investments | — | 2,911 |
| Other long-term assets | 531 | 770 |
| Restricted cash | 365 | 284 |
| Total assets | $98,169 | $143,452 |
| Liabilities and Stockholders’ Equity | ||
| Current liabilities: | ||
| Accounts payable | $2,535 | $1,973 |
| Accrued expenses and other current liabilities | 7,217 | 9,907 |
| Deferred revenue | 6,599 | 5,974 |
| Lease liabilities, short-term | 1,214 | 1,132 |
| Total current liabilities | 17,565 | 18,986 |
| Lease liabilities, long-term | 4,954 | 6,214 |
| Other long-term liabilities | 298 | 263 |
| Total liabilities | 22,817 | 25,463 |
| Commitments and contingencies (Note 14) | ||
| Stockholders’ equity: | ||
| Class A common stock, $0.01 par value; 210,000,000 shares authorized at December 31, 2024 and 2023; 37,729,242 shares and 37,099,909 shares issued and outstanding at December 31, 2024 and 2023, respectively | 377 | 371 |
| Class B common stock, $0.01 par value; 10,000,000 shares authorized at December 31, 2024 and 2023; 5,309,529 shares issued and outstanding at December 31, 2024 and 2023 | 53 | 53 |
| Preferred stock, $0.01 par value: 10,000,000 shares authorized at December 31, 2024 and 2023; zero shares issued and outstanding at December 31, 2024 and 2023 | — | — |
| Additional paid-in capital | 550,157 | 546,051 |
| Accumulated deficit | (475,274) | (428,385) |
| Accumulated other comprehensive income (loss) | 39 | (101) |
| Total stockholders’ equity | 75,352 | 117,989 |
| Total liabilities and stockholders’ equity | $98,169 | $143,452 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.